Tim Beaumont
29Patents
8h-index
21Co-inventors
71Inventor score
Filing activity: Dec 8, 2006 → Jan 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8568726B2 | RSV specific binding molecule | Chemistry; Metallurgy | 47 | Active |
| US8562996B2 | RSV-specific binding molecules and means for producing them | Chemistry; Metallurgy | 19 | Active |
| US8617556B2 | Gram-positive bacteria specific binding compounds | Physics | 11 | Active |
| US9283274B2 | RSV specific binding molecule | Chemistry; Metallurgy | 9 | Active |
| US10035843B2 | RSV-specific binding molecule | Chemistry; Metallurgy | 9 | Active |
| US9127251B2 | Means and methods for influencing the stability of antibody producing cells | Chemistry; Metallurgy | 8 | Active |
| US10059757B2 | RSV-specific binding molecules and means for producing them | Chemistry; Metallurgy | 8 | Active |
| US9321831B2 | RSV-specific binding molecules and means for producing them | Chemistry; Metallurgy | 8 | Active |
| US9090677B2 | Gram-positive bacteria specific binding compounds | Physics | 6 | Active |
| US9399673B2 | Gram-positive bacteria specific binding compounds | Physics | 6 | Active |
| US9206247B2 | Means and methods for producing high affinity antibodies | Chemistry; Metallurgy | 4 | Active |
| US9458228B2 | Gram-positive bacteria specific binding compounds | Physics | 3 | Active |
| US10723786B2 | RSV-specific binding molecule | Chemistry; Metallurgy | 3 | Active |
| US9266943B2 | Gram-positive bacteria specific binding compounds | Physics | 3 | Active |
| US10730931B2 | RSV-specific binding molecules and means for producing them | Chemistry; Metallurgy | 3 | Active |
| US9273118B2 | Means and methods for producing high affinity antibodies | Chemistry; Metallurgy | 2 | Active |
| US9718874B2 | Influenza A virus specific antibodies | Chemistry; Metallurgy | 1 | Active |
| US9718876B2 | RSV G protein specific antibodies | Physics | 0 | Active |
| US9969795B2 | Means and methods for producing high affinity antibodies | Chemistry; Metallurgy | 0 | Active |
| US9822339B2 | Means and methods for influencing the stability of antibody producing cells | Chemistry; Metallurgy | 0 | Active |
| US9688745B2 | Gram-positive bacteria specific binding compounds | Physics | 0 | Active |
| US11629200B2 | Means and methods for counteracting myeloproliferative or lymphoproliferative disorders | Physics | 0 | Active |
| US10344076B2 | Means and methods for producing high affinity antibodies | Chemistry; Metallurgy | 0 | Active |
| US9927428B2 | Gram-positive bacteria specific binding compounds | Physics | 0 | Active |
| US12084681B2 | Ex vivo antibody production | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.